ReliPoietin

Composition

Erythropoietin Concentrated Solution Ph. Eur. (rHuEPO) 4,000 IU in aqueous buffer

Indication

- the treatment of anemia associated with chronic renal failure, - in treatment of anemia in cancer patients on chemotherapy, - in treatment of anemia in zidovudine-treated HIV affected patients, and - in reduction of allogenic blood transfusions in surgery patients.

Dosage

For adult patients a dose of 100 units/kg intravenously or subcutaneously, TIW, for 8 weeks is recommended in whom serum erythropoietin levels are